American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Saltz
    Saltz
  4. Bajorin
    Bajorin
  5. O'Reilly
    O'Reilly
  6. Hudis
    Hudis
  7. Kris
    Kris
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Solid Tumor Oncology Division (5008)
  2. Department of Medicine (5003)
  3. Genitourinary Oncology Service (1607)
  4. Gastrointestinal Oncology Service (1211)
  5. Survivorship Research (1185)
  6. GSK Faculty (940)
  7. Epidemiology and Biostatistics (924)
  8. Surgery (804)
  9. Breast Medicine Service (785)
  10. Biostatistics Service (766)
Search Within
  1. "Solid Tumor Oncology Division"
Formats
  1. Meeting Abstract (3715)
  2. Journal Article (1189)
  3. Guidelines (31)
  4. Review (27)
  5. Editorial (26)
  6. Correspondence (18)
  7. Miscellaneous (2)
Groups
  1. Solid Tumor Oncology Division (5008)
  2. Department of Medicine (5003)
  3. Genitourinary Oncology Service (1607)
  4. Gastrointestinal Oncology Service (1211)
  5. Survivorship Research (1185)
  6. GSK Faculty (940)

More Groups

People
  1. Robert Motzer (417)
  2. Howard Scher (329)
  3. Leonard Saltz (279)
  4. Dean Bajorin (266)
  5. Eileen O'Reilly (259)
  6. Clifford Hudis (248)

More People

Years
  1. 2024 (11)
  2. 2023 (387)
  3. 2022 (376)
  4. 2021 (339)
  5. 2020 (373)
  6. 2019 (337)

More Years

Publications
  1. Journal of Clinical Oncology (4799)
  2. JCO Precision Oncology (88)
  3. American Society of Clinical Oncology Educational Book (54)
  4. Journal of Oncology Practice (46)
  5. JCO Clinical Cancer Informatics (14)
  6. JCO Oncology Practice (3)

More Publications

Results (5008)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association between objective responses (OR) and overall survival (OS) in patients (pts) with metastatic Merkel cell carcinoma (mMCC) treated with avelumab
    Meeting Abstract

    D'Angelo, S. P.; Hunger, M.; Schlichting, M.; Hennessy, M. G.; Bharmal, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Updated overall survival and safety profile of durvalumab monotherapy in advanced NSCLC
    Meeting Abstract

    Hellmann, M. D.; Antonia, S. J.; Balmanoukian, A. S.; Brahmer, J. R.; Ou, S. H. I.; Kim, S. W.; Ahn, M. J.; Kim, D. W.; Gutierrez, M.; Liu, S. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC) patients harboring activating molecular alterations
    Meeting Abstract

    Mhanna, L.; Milia, J.; Lusque, A.; Couraud, S.; Mascaux, C.; Veillon, R.; Frueh, M.; Moro-Sibilot, D.; Lattuca-Truc, M.; Tomasini, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Pan-cancer assessment of tumor mutational burden using a comprehensive genomic profiling assay
    Meeting Abstract

    Nichol, D.; Jones, S.; Angiouli, S. V.; Keefer, L.; Nesselbush, M.; Sengamalay, N.; White, J.; Simmons, J.; Diaz, L. A.; Velculescu, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • BEACON CRC study safety lead-in (SLI) in patients with BRAF(V600E) metastatic colorectal cancer (mCRC): Efficacy and tumor markers
    Meeting Abstract

    Van Cutsem, E.; Cuyle, P. J.; Huijberts, S.; Yaeger, R.; Schellens, J. H. M.; Elez, E.; Tabernero, J.; Fakih, M.; Montagut, C.; Peeters, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A tumor growth rate/overall survival model for atezolizumab as an early predictor of OS in patients with first or second line metastatic urothelial carcinoma
    Meeting Abstract

    Bruno, R.; Claret, L.; Wu, B.; Jin, J. Y.; Winter, H.; Cui, N.; Derleth, C. L.; Shen, X.; Girish, S.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • 18-month efficacy and safety update from JAVELIN Merkel 200 part A: A phase II study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
    Meeting Abstract

    D'Angelo, S. P.; Russell, J. S.; Bhatia, S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of lung and heart dose on survival after radiotherapy for esophageal cancer
    Meeting Abstract

    Oh, P.; Zhang, M.; Brady, P.; Yorke, E.; Won, E.; Goodman, K. A.; Wu, A. J. C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing to identify predictors of survival after trimodality therapy for esophageal cancer
    Meeting Abstract

    Oh, P.; Zhang, M.; Brady, P.; Sihag, S.; Molena, D.; Ilson, D. H.; Janjigian, Y. Y.; Ku, G. Y.; Wu, A. J. C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Evaluation of lesion-based response at 12 weeks (LBR12) of treatment (Rx) in metastatic colorectal cancer (mCRC): Findings from 9,092 patients (pts) in the ARCAD database
    Meeting Abstract

    Ou, F. S.; Lou, Y.; Van Cutsem, E.; Saltz, L.; Schmoll, H. J.; Goldberg, R. M.; Hoff, P.; Douillard, J. Y.; Hecht, J. R.; Hurwitz, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save